Purpose: To assess the feasibility of using perivenous-enhanced cortical veins (PECVs) visualized on contrast-enhanced black-blood MRI (CEBBI) for detecting and classifying blood-brain barrier disruption (BBBD) in patients with ischemic stroke.
Materials & methods: This retrospective study included 168 hospitalized patients with acute, subacute, and chronic ischemic stroke who underwent pre- and post-CEBBI imaging. BBBD was classified into three groups based on the enhancement ratio (ER) of normal-appearing white matter (NAWM) before and after contrast administration, as well as leptomeningeal and parenchymal enhancement patterns on CEBBI: no BBBD (NoBBBD), subtle BBBD (SuBBBD), and significant BBBD (SiBBBD). The number of PECVs was recorded bilaterally from the CEBBI source images. Univariate and multivariate linear regression analyses were performed to identify factors associated with BBBD.
Results: Increased BBBD was significantly associated with a higher number of PECVs in both the ipsilateral and contralateral hemispheres of the infarct (all p < 0.01). Patients with SuBBBD had significantly more PECVs than those with NoBBBD (median: 14 vs. 3, p < 0.01), and the SiBBBD group had significantly more PECVs than the SuBBBD group (median: 18 vs. 14, p < 0.01). In the ipsilateral hemisphere, a median PECV count of 4.5 distinguished NoBBBD from SuBBBD with 83.3% sensitivity and 83.1% specificity. Similarly, a median count of 8.5 PECVs discriminated SuBBBD from SiBBBD with 78.5% sensitivity and 85.0% specificity.
Conclusions: Our findings demonstrated that PECVs are more numerous in the SiBBBD group compared to SuBBBD and NoBBBD groups. The number of PECVs detected on high-resolution post-CEBBI provides a reliable, semi-quantitative method for identifying and classifying BBBD in patients with ischemic stroke. This method offers a direct assessment of BBB integrity and could improve clinical evaluation of stroke-related BBB disruption.
Keywords: Black-blood magnetic resonance imaging; Blood-brain barrier disruption; Contrast-enhanced; Cortical vein; Ischemic stroke.
© 2025. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.